Frontiers in Endocrinology | Pituitary Endocrinology

Original Research

Accepted on 16 Jan 2025

Efficacy in Japanese Adults with Growth Hormone Deficiency Receiving Weekly Somapacitan or Daily Growth Hormone: Results from Phase 3 REAL 1 Trial

in Pituitary Endocrinology

Fumio Otsuka
Michael Højby Rasmussen
Takaaki Endo
Claus Sværke
Shigeyuki Tahara
Gudmundur Johannsson

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1534891

Original Research

Published on 15 Jan 2025

Prevalence and predictive factors of testosterone-induced erythrocytosis: a retrospective single center study

in Pituitary Endocrinology

Anina Neidhart
Viktor von Wyl
Benno Käslin
Christoph Henzen
Stefan Fischli

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1496906

172 views

Original Research

Accepted on 07 Jan 2025

Patient Perspectives on Acromegaly Disease Burden: Insights from a Patient-Focused Community Meeting

in Pituitary Endocrinology

Shruti N. Shah
Kevin C.J. Yuen
Vivien Bonert
Wenyu Huang
Jill Sisco
Chrystal Palaty
Kristen Dancel-Manning
Nidhi Agrawal

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1516131

Original Research

Accepted on 06 Jan 2025

Impact of Strict IGF1 Control on Quality-of-Life Scores in Patients with Acromegaly

in Pituitary Endocrinology

Chaitanya Gandhi
Marie-Claire Denis
Daniel Holmes
Juan Rivera
Stan Van Uum
Shereen Ezzat
Constance Chik

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1516899

Original Research

Published on 23 Dec 2024

Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing’s syndrome

in Pituitary Endocrinology

Yasutaka Tsujimoto
Naoki Yamamoto
Hironori Bando
Masaaki Yamamoto
Yuka Ohmachi
Yuma Motomura
Yuka Oi-Yo
Yuriko Sasaki
Masaki Suzuki
Shin Urai

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1511155

366 views

Correction

Accepted on 18 Dec 2024

Corrigendum: [A clinical practical model for preoperative prediction of visual outcome for pituitary adenoma patients in a retrospective and prospective study]

in Pituitary Endocrinology

Zijian Zheng
He Wang
Qianxi Chen
zhicheng wang
Jun Fu
Wenjian Fan
Yuanxiang Lin
Dezhi Kang
Changzhen Jiang
Zhangya Lin

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1546763

Original Research

Published on 17 Dec 2024

Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly

in Pituitary Endocrinology

Jowita Halupczok-Żyła
Aleksandra Jawiarczyk-Przybyłowska
Marek Bolanowski

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1472680

412 views

Mini Review

Published on 16 Dec 2024

Everolimus in pituitary tumor: a review of preclinical and clinical evidence

in Pituitary Endocrinology

Zihong Yao
Hui Chen

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1456922

480 views

Original Research

Published on 13 Dec 2024

A clinical practical model for preoperative prediction of visual outcome for pituitary adenoma patients in a retrospective and prospective study

in Pituitary Endocrinology

Zijian Zheng
He Wang
Qianxi Chen
Zhicheng Wang
Jun Fu
Wenjian Fan
Yuanxiang Lin
Dezhi Kang
Changzhen Jiang
Zhangya Lin

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1479442

475 views

Review

Published on 13 Dec 2024

Pasireotide-induced hyperglycemia in Cushing’s disease and Acromegaly: A clinical perspective and algorithms proposal

in Pituitary Endocrinology

Przemysław Witek
Marek Bolanowski
Adam Krętowski
Aleksandra Głowińska

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1455465

722 views

Original Research

Published on 06 Dec 2024

Comparative analysis of clinical characteristics of symptomatic pituitary adenomas in elderly patients: a consecutive series of 114 patients

in Pituitary Endocrinology

Run Wang
Xiaodi Han
Cheng Xie
Qinghua Zhang
Liang Kan
Sheng Han

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1385813

357 views

Original Research

Published on 28 Nov 2024

Elucidating the causal links between plasma and cerebrospinal fluid metabolites and pituitary tumors: a Mendelian randomization analysis

in Pituitary Endocrinology

Wencai Wang
Menghao Liu
Zun Wang
Wei Ye
Xianfeng Li

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1460278

768 views

Review

Published on 22 Nov 2024

The prospective roles of exosomes in pituitary tumors

in Pituitary Endocrinology

Paulina Lisiewicz
Małgorzata Szelachowska
Adam Jacek Krętowski
Katarzyna Siewko

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1482756

1,091 views

Review

Published on 21 Nov 2024

Growth hormone/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulin

in Pituitary Endocrinology

Kevin C. J. Yuen
Rikke Hjortebjerg
Ashok Ainkaran Ganeshalingam
David R. Clemmons
Jan Frystyk

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1456195

933 views

Mini Review

Published on 20 Nov 2024

Practical application of precision oncology in adult onset craniopharyngiomas

in Pituitary Endocrinology

Chandrima Biswas
Guilherme Mansur
Kyle C. Wu
Daniel M. Prevedello
Luma Ghalib

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1488958

730 views

Original Research

Published on 20 Nov 2024

Quantitative and qualitative assessment of a pituitary neuroendocrine tumor’s T2-signal intensity in acromegaly – a call for unification

in Pituitary Endocrinology

Magdalena Godlewska-Nowak
Anna Grochowska
Grzegorz Zieliński
Anna Bogusławska
Dariusz Adamek
Maria Maksymowicz
Alicja Hubalewska-Dydejczyk
Aleksandra Gilis-Januszewska

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1441745

671 views

Navigation group

Articles

Efficacy in Japanese Adults with Growth Hormone Deficiency Receiving Weekly Somapacitan or Daily Growth Hormone: Results from Phase 3 REAL 1 Trial

Prevalence and predictive factors of testosterone-induced erythrocytosis: a retrospective single center study

Patient Perspectives on Acromegaly Disease Burden: Insights from a Patient-Focused Community Meeting

Impact of Strict IGF1 Control on Quality-of-Life Scores in Patients with Acromegaly

Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing’s syndrome

Corrigendum: [A clinical practical model for preoperative prediction of visual outcome for pituitary adenoma patients in a retrospective and prospective study]

Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly

Everolimus in pituitary tumor: a review of preclinical and clinical evidence

A clinical practical model for preoperative prediction of visual outcome for pituitary adenoma patients in a retrospective and prospective study

Pasireotide-induced hyperglycemia in Cushing’s disease and Acromegaly: A clinical perspective and algorithms proposal

Comparative analysis of clinical characteristics of symptomatic pituitary adenomas in elderly patients: a consecutive series of 114 patients

Elucidating the causal links between plasma and cerebrospinal fluid metabolites and pituitary tumors: a Mendelian randomization analysis

The prospective roles of exosomes in pituitary tumors

Growth hormone/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulin

Practical application of precision oncology in adult onset craniopharyngiomas

Quantitative and qualitative assessment of a pituitary neuroendocrine tumor’s T2-signal intensity in acromegaly – a call for unification